Interventional Rhythm Management, Inc. Announces its Revolutionary Technology Platform for Cardiac Electrophysiology Devices

The IRM IID™ represents a major breakthrough technology for the significantly underserved patient population of defibrillator candidates. Richard S. Stack MD, President, IRM Fundamental Patent Application Published December 4th, 2004. Research Triangle Park, NC – January 12, 2005 – Interventional Rhythm Management Inc. today announces its revolutionary design for cardiac electrophysiology devices, such as implantable defibrillators and pacemakers. IRM’s ground-breaking …

Guidant Acquires Majority Stake in Bioabsorbable Stent Company

Guidant is enthusiastic about the potential of bioabsorbable stents, which represent a new frontier in the treatment of coronary artery disease. Dana G. Mead, Jr., President, Vascular Intervention, Guidant Corporation INDIANAPOLIS, Apr 1, 2003 (BUSINESS WIRE) — Guidant Corporation (NYSE:GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Guidant will acquire an early-stage company …

BaroSense, Inc. Raises $6.2 million in Series A Round

We are pleased to be partnering with the thought leaders in bariatric surgery, gastroenterology, and endocrinology … to develop devices to treat obesity. Nathan Every, M.D. Menlo Park, CA and Research Triangle Park, NC – September 20, 2002 – BaroSense Inc., a medical device company specializing in the minimally invasive treatment of obesity, announces that it has secured $6.2 million …

Article: Growing Companies – Part II [excerpt from Start-Up, January 2002]

These are things that are going to change the way medicine is practiced! Richard S. Stack MD, Managing Director of Synecor LLC Incubators are hot and as their numbers multiply, so do the number of different models and approaches that these development partners take. The second of a two-part series. [download_link link=”https://www.synecor.com/news/Start_Up_Article.pdf”]Full Story PDF[/download_link]

Guidant, GE, and Duke University Take Stake in SyneCor, LLC

This is a groundbreaking partnership that allows each of our major investors a first look at cutting-edge health sciences technologies. Bill Starling, Managing Director of Synecor, LLC Menlo Park, Calif. – Dec. 12, 2000 – SyneCor, LLC, an accelerator company for new cardiovascular research, devices and development businesses, today announced that it has secured financing led by Frazier Healthcare and …